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Abstract 27 
 28 
Capnocytophaga canimorsus, a commensal bacterium of dog’s mouth flora causing 29 
severe infections in humans after dog bites or scratches, has a lipopolysaccharide (LPS, 30 
endotoxin) with low-inflammatory lipid A. In particular it contains a phosphoethanolamine 31 
(P-Etn) instead of a free phosphate group at the C-1 position of the lipid A backbone, 32 
usually present in highly toxic enterobacterial Gram-negative lipid A. Here we show that 33 
the C. canimorsus genome comprises a single operon encoding a lipid A 1-phosphatase 34 
(LpxE) and a lipid A 1 P-Etn transferase (EptA). This suggests that lipid A is modified 35 
during biosynthesis after completing acylation of the backbone by removal of the 1-36 
phosphate and subsequent addition of a P-Etn group. As endotoxicity of lipid A is known 37 
to depend largely on the degree of unsubstituted or unmodified phosphate residues, 38 
deletion of lpxE or eptA led to mutants lacking the P-Etn group, with consequently 39 
increased endotoxicity and decreased resistance to cationic antimicrobial peptides 40 
(CAMP). Consistent with the proposed sequential biosynthetic mechanism, the 41 
endotoxicity and CAMP resistance of a double deletion mutant of lpxE-eptA was similar 42 
to that of a single lpxE mutant. Finally, the proposed enzymatic activities of LpxE and 43 
EptA based on sequence similarity could be successfully validated by MS-based 44 
analysis of lipid A isolated from corresponding deletion mutant strains. 45 
212 words 46 
47 
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Introduction 48 
 49 
Some Gram-negative bacteria have evolved different modifications of their lipid A 50 
structure, leading to a reduced recognition by the host and sensitivity to CAMP (1-7). 51 
One of these modifications occurs on the 1- or on the 4’-phosphate of lipid A (1, 4, 7-10). 52 
4’-phosphatases (LpxF) have been described in Rhizobium leguminosarum, Rhizobium 53 
etli, Porphyromonas gingivalis, Francisella species and Helicobacter pylori (1, 10-12). 54 
Deletion of lpxF and the resulting presence of the 4’-phosphate on lipid A leads to 55 
increased endotoxicity (1, 12) and decreased resistance to CAMP (10, 12). In the case 56 
of Francisella and H. pylori virulence is reduced (11, 12, 13 ). 1-phosphatases (LpxE) 57 
have been identified in H. pylori, P. gingivalis, R. etli and others (1, 6, 10, 12, 14-16). 58 
Deletion of lpxE and the resulting presence of the 1-phosphate on lipid A leads to a 59 
slightly increased endotoxicity (1) and CAMP sensitivity (10). In H. pylori, the 1 position 60 
is further modified by the addition of a P-Etn (15, 17, 18), a modification known from 61 
other bacteria (15, 17, 18). This happens via a two-step mechanism, which first involves 62 
dephosphorylation of one phosphate residue located at position C-1 of the lipid A 63 
backbone by LpxE and subsequent P-Etn transfer by a phosphoethanolamine 64 
transferase (EptA or PmrC) (15, 16). In H. pylori lpxE and eptA are encoded by one 65 
operon (Hp0021-Hp0022) (16). 66 
We have previously characterized the lipid A structure of C. canimorsus (19), bacteria 67 
causing rare but severe sepsis or meningitis in humans after dog bites or scratches (20-68 
24). C. canimorsus belongs to the family of Flavobacteriaceae in the phylum 69 
Bacteroidetes and are usual members of dog’s mouth flora (21, 25-28). C. canimorsus 70 
lipid A consists of a 2,3-diamino-2,3-dideoxy-D-glucose (GlcN3N’) β-(1’→6)-linked to 71 
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2-amino-2-deoxy-D-glucose (GlcN) [ß-D-GlcpN3N’-(1→6)-D-GlcpN lipid A hybrid 72 
backbone] containing a P-Etn group attached to the C-1 reducing end and lacking a 4’-73 
phosphate (Fig. 1 A). 3-hydroxy-15-methylhexadecanoic acid [i17:0(3-OH)], 3-hydroxy-74 
13-methyltetradecanoic acid (i15:0), 3-O-(13-methyltetradecanoyl)-15-75 
methylhexadecanoic acid [i17:0[3-O(i15:0)]] and 3-hydroxyhexadecanoic acid [16:0(3-76 
OH)] are attached to the backbone at positions 2, 3, 2’, and 3’, respectively (19). This 77 
structure differs from that of a potent Toll-like receptor 4 (TLR4) agonist like the E. coli 78 
lipid A (Fig. 1 B), consisting of a β-(1’→6)-linked GlcN disaccharide that is 79 
phosphorylated at positions 1 and 4’ and carries four (R)-3-hydroxymyristate chains 80 
[14:0(3-OH)] (at positions 2’, 3’, 2 and 3). The 2’ and 3’ 3-hydroxylated acyl groups in 81 
GlcN(II) are further esterified with laurate and myristate, respectively (29). 82 
We have identified genes lpxE and eptA in the genome of C. canimorsus and found the 83 
overlapping genes to be organized in one operon. We show that the deletion of lpxE or 84 
eptA leads to increased endotoxicity and decreased resistance to CAMP, where deletion 85 
of lpxE has a more severe effect. Interestingly, the endotoxicity and CAMP resistance of 86 
a double deletion mutant of lpxE and eptA was the same as that of a single lpxE mutant. 87 
This suggests that the P-Etn containing lipid A is synthesized by a similar two-step 88 
enzymatic process as in H. pylori, where dephosphorylation is necessary for substitution 89 
of 1-phosphate with P-Etn. Finally, we could successfully validate the proposed lipid A 90 
structures of the respective deletion mutants by MS-analysis, thus also further 91 
confirming, on a structural basis, the proposed enzymatic activities of LpxE and EptA as 92 
well as the two-step enzymatic mechanism in the lipid A biosynthesis. 93 
 94 
 95 
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Materials and Methods 96 
 97 
Bacterial strains and growth conditions. The strains used in this study are listed in 98 
Table 1. E. coli strains were grown in LB broth at 37°C. C. canimorsus 5 (Cc5) (30) was 99 
routinely grown on Heart Infusion Agar (HIA; Difco) supplemented with 5% sheep blood 100 
(Oxoid) for 2 days at 37°C in presence of 5% CO2. Bacteria were harvested by scraping 101 
colonies off the agar surface, washed and re-suspended in phosphate buffered saline 102 
(PBS). Selective agents were added at the following concentrations: erythromycin, 10 103 
μg/ml; cefoxitin, 10 μg/ml; gentamicin, 20 μg/ml; ampicillin, 100 μg/ml; tetracycline, 10 104 
μg/ml. 105 
 106 
Genetic manipulations of C. canimorsus. Genetic manipulations of Cc5 wt have been 107 
described (31). Briefly, replacement cassettes with flanking regions spanning 108 
approximately 500 bp homologous to direct lpxE or eptA framing regions (28) were 109 
constructed with a three-fragment overlapping-PCR strategy. As the ATG of eptA is 110 
within the coding region of lpxE, 106bp upstream of the eptA ATG were not deleted in 111 
lpxE single knockout (∆ 1833737 - 1833995). First, two PCRs were performed on 100 ng 112 
of Cc5 genomic DNA with primers A and B (Table 2) for the upstream flanking regions 113 
and with primers E and F for the downstream regions. Primers B and E contained an 114 
additional 5' 20-nucleotide extension homologous to the ermF or tetQ insertion 115 
cassettes. The ermF and tetQ resistance cassettes were amplified from plasmids 116 
pMM13 and pMM104.A DNA respectively with primers C and D. All three PCR products 117 
were cleaned and then mixed in equal amounts for PCR using Phusion polymerase 118 
(Finnzymes). The initial denaturation was at 98°C for 2 min, followed by 12 cycles 119 
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without primers to allow annealing and elongation of the overlapping fragments (98°C for 120 
30 s, 50°C for 40 s, and 72°C for 2 min). After the addition of external primers (A and F), 121 
the program was continued with 20 cycles (98°C for 30 s, 50°C for 40 s, and 72°C for 2 122 
min 30 s) and finally 10 min at 72°C. Final PCR products consisting in lpxE::ermF, 123 
eptA::ermF, lpxE/eptA/::ermF, lpxE::tetQ, eptA::tetQ, lpxE/eptA/::tetQ insertion cassettes 124 
were then digested with PstI and SpeI for cloning into the appropriate sites of the C. 125 
canimorsus suicide vector pMM25 (31). Resulting plasmids were transferred by RP4-126 
mediated conjugative DNA transfer from E. coli S17-1 to C. canimorsus 5 or C. 127 
canimorsus 5 Y1C12 mutant to allow integration of the insertion cassette. 128 
Transconjugants were then selected for the presence of the ermF or tetQ cassette on 129 
erythromycin or tetracycline plates respectively and checked for sensitivity to cefoxitin. 130 
Deletion of the appropriate regions was verified by PCR.  131 
 132 
Construction of complementation plasmids. Plasmid pMM47.A was used for 133 
expression of LpxE and EptA (31). Full length lpxE, eptA or lpxE-eptA genes were 134 
amplified with the specific primers listed in Table 2 and cloned into plasmid pMM47.A 135 
using NcoI and XbaI or NcoI and XhoI restriction sites leading to the insertion of a 136 
glycine at position 2. Ligated plasmids were cloned in E. coli top10. 137 
 138 
Human TLR4 activation assay. HEK293 stably expressing human TLR4, myeloid 139 
differentiation factor-2 (MD-2), cluster of differentiation antigen 14 (CD14) and a NFκB 140 
dependent reporter (secreted embryonic alkaline phosphatase) were from InvivoGen 141 
(HEKBlueTM hTLR4). Growth conditions and endotoxicity assay were performed as 142 
recommended by the supplier (InvivoGen). Briefly, desired amounts of heat-killed 143 
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bacteria were placed in a total volume of 20 μl (diluted in PBS) and distributed in a flat-144 
bottom 96-well plate (BD Falcon). 25000 HEKBlueTM hTLR4 cells in 180 µl were then 145 
added and the plate was incubated for 20-24h at 37°C and 5% CO2. Detection of the 146 
secreted phosphatase followed the QUANTI-BlueTM protocol (InvivoGen). 20 μl of 147 
challenged cells were incubated with 180 μl detection reagent (QUANTI-BlueTM, 148 
InvivoGen). Plates were incubated at 37°C and 5% CO2 and absorbance was measured 149 
at 655 nm using a spectrophotometer (BioRad). 150 
 151 
Polymyxin B sensitivity assay. Polymyxin B sulphate was obtained from Sigma-152 
Aldrich. The minimal inhibitory concentration (MIC) was determined by the agar dilution 153 
method based on the CLSI/NCCLS recommendations (32). Briefly, 104 bacteria 154 
contained in 2 μl PBS were spotted on HIA 5% sheep blood plates containing Polymyxin 155 
B ranging from 0.5 mg/L to 1024 mg/L (2-fold increase per step).  Plates were incubated 156 
and examined for growth of visible colonies after 48h and 72h. 157 
 158 
Genome annotation. Blast-p search tool (33) against the C. canimorsus 5 genome (28) 159 
was used. Search sequences were obtained from the National Center for Biotechnology 160 
Information. All available Bacteroidetes-group sequences were used as search, but also 161 
standard E. coli sequences have always been included. The highest scoring subjects 162 
over all the searches have been annotated as corresponding enzymes. Difficulties in 163 
annotation were only observed for lpxE. lpxE search was based on lpxF and/or lpxE 164 
protein sequences from P. gingivalis (1), F. novicida (7), R. etli (10), H. pylori (12, 16) 165 
and on all available Bacteroidetes-group pgpB protein sequences.  166 
 167 
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Preparation of bacteria for LPS extraction. Compositional analysis of the LPS from 168 
the C. canimorsus 5 wt strain previously showed to be highly contaminated with glucose 169 
from amylopectin, flavolipin, and capnin, known to be present in Capnocytophaga spp. 170 
and Flavobacteriaceae (34). In contrast, the LPS from the C. canimorsus 5 Y1C12 171 
mutant (35) was devoid of such contaminating material. Since the compositional 172 
analysis of the lipid A and LPS core obtained from the wt strain LPS and that of the 173 
Y1C12 mutant revealed no differences with respect to their sugars and fatty acids (19, 174 
34), the Y1C12 mutant was chosen as background strain to isolate and analyse the lipid 175 
A of ΔeptA, ΔlpxE and ΔlpxE-eptA deletion mutants in detail by MS analysis. While the 176 
Y1C12 mutant was chosen as background strain for MS analysis, please note that 177 
human TLR4 activation assays and Polymyxin B sensitivity analysis are based on C. 178 
canimorsus 5 ΔeptA, ΔlpxE and ΔlpxE-eptA deletion mutants and complemented 179 
mutants based thereon. The C. canimorsus 5-based Y1C12 mutant has a transposon 180 
insertion within a predicted glycosyltranferase-encoding gene, probably the N-acetyl 181 
fucosamine transferase WbuB, necessary for the formation of the O-antigen (35). 182 
Endotoxicity of resulting C. canimorsus 5 Y1C12 ΔeptA, ΔlpxE and ΔlpxE-eptA deletion 183 
mutants was assessed and confirmed results obtained with C. canimorsus 5 ΔeptA, 184 
ΔlpxE and ΔlpxE-eptA deletion mutants (data not shown). C. canimorsus bacteria were 185 
harvested from 25 blood plates in PBS, followed by centrifugation at 18,000 x g for 30 186 
min. Bacteria were resuspended in cold acetone, incubated with shaking, resuspended 187 
in PBS containing 0.5% phenol for killing, again harvested by centrifugation, washed 188 
with PBS and resuspended in 1ml water. 1/10 of the volume was plated on appropriate 189 
growth plates to ensure complete bacterial killing. Bacteria were air dried prior to LPS 190 
extraction. 191 
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 192 
Purification and isolation of free lipid A suitable for MS-analysis. Lipid A was 193 
isolated from lyophilized C. canimorsus cell pellets following the Caroff extraction 194 
method (36). Briefly, pellets were dissolved in 70% isobutyric acid and 1M ammonium 195 
hydroxide and incubated at 100°C for one hour. 400 ul of water was added, the samples 196 
were snap-frozen on dry ice and lyophilized overnight. Samples were then washed twice 197 
with 1ml methanol and reconstituted in 150ul chloroform:methanol:water (3:1.5:0.25, 198 
v:v:v).  199 
 200 
MS based structural analysis. Lipid A structures were assessed by negative and 201 
positive-ion MALDI-TOF MS. Lyophilized lipid A was extracted in chloroform/methanol 202 
and then 1 μl was mixed with 1μl of norharmane MALDI matrix. All MALDI-TOF 203 
experiments were performed using a Bruker Microflex MALDI-TOF mass spectrometer 204 
(Bruker Daltonics, Billerica, MA). Each spectrum was an average of 300 shots. ES 205 
tuning mix (Aligent, Palo Alto, CA) was used for calibration. Data were analyzed using 206 
Bruker Daltonik flex Analysis software.  207 
 208 
Immunoblotting of proteinase K-resistant structures. Bacteria were harvested from 209 
blood-agar plates, washed once in 1ml of PBS and adjusted to an OD600 of 1.5 in PBS. 210 
500µl bacterial suspension was pelleted and dissolved in 125µl loading buffer (1% 211 
sodium dodecyl sulfate [SDS], 10% glycerol, 50 mM dithiothreitol, 0.02% bromophenol 212 
blue, 45 mM Tris (pH 6.8) in ddH2O). Samples were boiled at 99°C for 10 min. 213 
Proteinase K (50µg/ml final concentration) was added and samples were incubated at 214 
37°C overnight. After incubation samples were boiled again for 10 min at 99°C and a 215 
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second volume of proteinase K (equal to the first) was added. Samples were incubated 216 
at 55°C for 3 h, boiled again for 5 minutes at 99°C and loaded on a 15% SDS-PAGE. 217 
Samples were analyzed by western blotting using polyclonal, C. canimorsus 5 Y1C12-218 
absorbed, serum against C. canimorsus 5. This antibody was generated from rabbits by 219 
immunization with heat killed C. canimorsus 5 (Laboratoire d’Hormonologie, Marloie, 220 
Belgium). Further on, the C. canimorsus 5 Y1C12-absorbed serum was prepared by 221 
incubating twice an excess amount of Y1C12 mutant C. canimorsus 5 bacteria 222 
(harvested from blood plates and washed in PBS) with anti-C. canimorsus 5 serum at 223 
4°C for 12 h. Bacteria were removed by repeated centrifugation. This results in an 224 
antiserum recognizing C. canimorsus 5 LPS (35). 225 
 226 
227 
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Results and Discussion 228 
 229 
Identification of enzymes leading to the presence of 1 P-Etn on lipid A. The 230 
genome of C. canimorsus 5 (28) (Embank: YP_004740918.1) was analyzed for proteins 231 
with high sequence similarity to the lipid A modifying enzymes, LpxE and EptA. Our 232 
search for a lipid A phosphatase was based on LpxE and/or LpxF sequences from P. 233 
gingivalis (1), F. novicida (11), R. etli (10) H. pylori (12, 16) and on all available 234 
Bacteroidetes-group pgpB sequences. Three lpxE/F candidates were found 235 
(Ccan_16960, Ccan_14540 and Ccan_06070) and individually deleted. Interestingly, the 236 
gene downstream of Ccan_16960 (Genbank: YP_004740919.1), Ccan_16950 was 237 
found to have high sequence similarity to eptA, coding for a lipid A P-Etn transferase. 238 
Ccan_16950 and 16960 form an operon and the two genes overlap by 20 base pairs 239 
(bp) (Fig. 2, lower panel). Ccan_16960 has thus been annotated as lpxE, an annotation 240 
validated by mutagenesis, MS analysis and impact on endotoxicity and CAMP 241 
resistance, as described here below. The association of lpxE and eptA genes reinforces 242 
the idea that the two gene products acts in the same pathway and suggests that the 243 
modification of lipid A that they determine together is essential for survival in the dog's 244 
mouth environment. 245 
 246 
Predicted lipid A structures in eptA, lpxE and lpxE-eptA deletion mutants. EptA 247 
has been proposed not to be active on lipid A, in case the 1-phosphate has not been 248 
removed before by LpxE (15, 16). Hence, deletion of the lipid A 1-phosphatase LpxE, 249 
the enzyme proposed to act first in this two-step mechanism, should result in a lipid A 250 
having a 1-phosphate (Fig. 2). Upon deletion of only the second enzyme acting in the 251 
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pathway, the P-Etn transferase EptA, a free hydroxy group at the “reducing end” of the 252 
lipid A backbone should result (Fig. 2). This would reflect that LpxE is still active even in 253 
the absence of EptA (15, 16). The resulting lipid A in the eptA deletion mutant is thus 254 
predicted to lack both the 4’ and the 1-phosphate. In case of a double deletion mutant in 255 
lpxE and eptA, the same 1-phospho lipid A is predicted as for the single deletion in lpxE 256 
(Fig. 2). 257 
The 1-phospho lipid A variant predicted for ΔlpxE and ΔlpxE-eptA should be the variant 258 
with the highest endotoxicity. In case of an eptA deletion mutant, the free (hydroxy) 4’ 259 
and 1 position should result in a very low endotoxic lipid A as it is known from 260 
completely de-phosphorylated synthetic lipid A analogues (37). 261 
 262 
LpxE and EptA impact on endotoxicity. To study the endotoxic activity after the 263 
removal of the 1-phosphate or the addition of a P-Etn to the free 1 position of lipid A, we 264 
engineered ΔeptA and ΔlpxE mutations and monitored endotoxicity using a HEK293 cell 265 
line overexpressing human TLR4/MD-2/CD14 and a secreted reporter protein 266 
(HEKBlueTM human TLR4 cell line). Activation of this cell line essentially depends on 267 
TLR4 and other TLR stimuli may be neglected. Heat killed bacteria from both mutant 268 
strains showed increased endotoxicity compared to wt bacteria and mutation of lpxE had 269 
a more severe impact on endotoxicity (Fig. 3 A). Heat killed C. canimorsus ΔlpxE-eptA 270 
exhibited identical endotoxicity as C. canimorsus ΔlpxE (Fig. 3 A). 271 
Complementation of the deleted genes with plasmid-borne genes expressed from the 272 
ermF promoter restored endotoxicity to the wt level indicating that none of the mutation 273 
was polar (Fig. 3 B, C and D). The ΔlpxE strain could be complemented in trans with 274 
lpxE or lpxE-eptA, but not with eptA alone (Fig. 3 B). A slight increase in TLR4 activation 275 
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of the ΔlpxE strain complemented with eptA compared to the ΔlpxE strain was observed 276 
(Fig. 3 B). This might be explained by transfer of P-Etn to other parts of the LPS 277 
molecule, as suggested by sequence similarity to the 3-deoxy-D-manno-oct-2-ulosonic 278 
acid (Kdo) P-Etn transferase EptB (38). Finally, the ΔeptA strain was complemented 279 
with eptA or lpxE-eptA (Fig. 3 C) and the lpxE-eptA deletion mutant was complemented 280 
with lpxE-eptA (Fig. 3 D). We conclude from these complementation experiments that 281 
the eptA and lpxE mutations were non-polar. 282 
To exclude a strong impact on TLR4 activation upon mutation of lpxE, eptA or lpxE and 283 
eptA due to varying levels of LPS or LPS made accessible by heat killing, we 284 
determined the LPS amount in all strains by Western-blot experiments on equal amount 285 
of proteinase K treated bacterial lysates with a C. canimorsus 5 LPS specific antiserum 286 
(Fig. S1). We observed similar LPS band intensities for all strains tested, indicating that 287 
LPS amounts present in the bacteria and made accessible by heat treatment are not 288 
dramatically changed upon mutation of lpxE, eptA or lpxE and eptA. Notably, a slight 289 
size-shift of the LPS band was observed for all strains predicted not to exhibit a wt lipid 290 
A (ΔlpxE, ΔeptA, ΔlpxE-eptA and ΔlpxE + p-eptA). Migration pattern is altered for all 291 
strains predicted not to have the positively charged ethanolamine moiety present, which 292 
might explain this observation. 293 
 294 
LpxE and EptA increase resistance to Polymyxin B. Lipid A modifications have been 295 
shown not only to affect endotoxicity, but also to alter resistance to CAMP such as 296 
Polymyxin B (10, 29, 39, 40). Hence, we monitored the MIC of Polymyxin B for C. 297 
canimorsus wt, ΔlpxE, ΔeptA and the double-knockout ΔlpxE-eptA strains. C. 298 
canimorsus wt was highly resistant to Polymyxin B, as it was still able to grow in the 299 
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presence of 512 mg/L Polymyxin B (MIC ≥1024 mg/L) (Fig. 4). The MIC decreased to 300 
512 mg/L for ΔeptA mutant bacteria and to 128 mg/L for the ΔlpxE bacteria, showing an 301 
increased sensitivity to Polymyxin B (Fig. 4). The C. canimorsus lpxE-eptA double-302 
mutant had the same MIC as the single ΔlpxE mutant (Fig. 4). The ΔlpxE strain could be 303 
complemented in trans with lpxE, but not with eptA alone (Fig. 4). The ΔeptA strain was 304 
complemented with eptA (Fig. 4) and the lpxE-eptA deletion mutant was complemented 305 
with lpxE-eptA (Fig. 4). We conclude from these complementation experiments that the 306 
lpxE, eptA and lpxE-eptA mutations were non-polar. 307 
 308 
The P-Etn modification at position C-1 thus contributed to the low endotoxicity and 309 
Polymyxin B resistance of C. canimorsus, as was shown for H. pylori (12). The identical 310 
phenotype in endotoxicity and Polymyxin B sensitivity of the single ΔlpxE and the double 311 
ΔlpxE-eptA mutants suggests that the P-Etn containing lipid A is synthesized by a two-312 
step enzymatic process similar to that described for H. pylori (15, 16). In H. pylori, lipid A 313 
also carries a P-Etn group at position C-1, generated in the course of the LPS 314 
biosynthesis by removal of the lipid A 1-phosphate by LpxE followed by transfer of a P-315 
Etn residue by EptA from phosphatidylethanolamine to the free reducing end of GlcN(I), 316 
where dephosphorylation is necessary for substitution of 1-phosphate with P-Etn (12, 317 
15, 16). The non-polar deletion of lpxE in C. canimorsus does not prevent the synthesis 318 
of EptA but likely leads to a lipid A with a 1-phosphate group, which would explain the 319 
high endotoxicity observed for this strain. Therefore, as in H. pylori, the C. canimorsus 320 
EptA seems to accept only the free reducing end of the lipid A backbone generated by 321 
the activity of LpxE as a substrate. 322 
 323 
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The ΔlpxE mutation had a more severe effect than the one of ΔeptA, both with respect 324 
to endotoxicity and Polymyxin B sensitivity. The difference between the two mutants can 325 
be explained by the fact that EptA adds a negative and a positive charge, whereas LpxE 326 
only removes a negative charge. In the two-step mechanism, the ΔlpxE mutation would 327 
lead to an increase of a negative charge (the unsubsituted 1-phosphate) compared to 328 
the wt, while the ΔeptA mutation would result in a free reducing end of lipid A as 329 
compared to the P-Etn in the wt. As net negative charges are important for interaction 330 
with CAMP as well as with TLR4/MD-2 (41) one would expect ΔlpxE to affect 331 
endotoxicity and CAMP sensitivity more than ΔeptA, which we found. This again 332 
supports the two-step enzymatic process of formation of the 1 P-Etn.  333 
It is noteworthy that one would expect the mutation of eptA not to affect any charge 334 
dependent mechanisms, as no net charge change is expected. C. canimorsus ΔeptA 335 
bacteria showed increased endotoxicity and decreased CAMP resistance as the wt lipid 336 
A, while the lipid A variant predicted for a ΔeptA deletion mutant is lacking both the 1 337 
and 4’-phosphate in the lipid A backbone. The C. canimorsus 1-dephospho lipid A in a 338 
ΔeptA mutant is not expected to be endotoxic at all, as this lipid A species lacks both 339 
phosphates, and thus the negative charges which are important for endotoxicity (41). 340 
Still the ΔeptA mutation had a small phenotype in Polymyxin B sensitivity and a more 341 
pronounced phenotype in endotoxicity. This hints at a heterogeneous lipid A population 342 
in the ΔeptA strain, which could result from a restricted activity of LpxE. Assuming a 343 
non-stoichiometric activity of LpxE in the ΔeptA strain, both the lipid A containing a free 344 
reducing end as well as the 1-phosphate at GlcN(I) should be present. In this case, the 345 
1-phospho lipid A variant could account for the increase in endotoxicity, while its 346 
reduced amounts as compared to ΔlpxE would explain the higher endotoxicity of the 347 
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ΔlpxE over the ΔeptA deletion mutant strain. It might thus be that the accumulation of 1-348 
dephosphorylated lipid A exerts a feedback regulatory effect on the activity of LpxE, 349 
preventing full dephosphorylation in the absence of EptA. The fraction of 1-phospho lipid 350 
A would thus increase, which would then be responsible for the observed increase in 351 
endotoxicity and sensitivity to Polymyxin B. 352 
 353 
MS-based structural analysis of eptA, lpxE and lpxE-eptA deletion mutants. In 354 
order to validate the enzymatic activities proposed for LpxE and EptA and the predicted 355 
two-step enzymatic mechanism, we performed MS-based structural analysis of isolated 356 
lipid A species of the corresponding deletion mutants. One of the predicted lipid A 357 
structure, the 4’- and 1-hydroxy lipid A in case of the ΔeptA deletion mutant is devoid of 358 
any negative charge and thus not accessible to be analyzed in the negative ion mode. 359 
Therefore, negative and positive ion mode MS was run to determine all lipid A variants 360 
expected based on the genetic analysis and endotoxic activity, respectively. 361 
 362 
In the negative ion mode, MS analysis confirmed the wt lipid A (m/z calculated: 1716.3, 363 
m/z found: 1717) (Table 3 and Fig. 5). Observed mass differences of 14 m/z units (m/z 364 
1731 or 1703) were assigned to acyl chain heterogeneity. For all samples analyzed by 365 
MS such peak “clusters” differing by Δ14 m/z units were found, suggesting that acyl 366 
chain heterogeneity was independent of lpxE or eptA mutagenesis. This is in agreement 367 
with our previous data on wt C. canimorsus lipid A (19, 34). 368 
In the negative ion mode all deletion mutant strains (ΔeptA, ΔlpxE and ΔlpxE-eptA) 369 
showed a main peak at m/z of 1674 (Table 3, Fig. 5). The 1-phospho lipid A variant 370 
predicted for ΔlpxE and ΔlpxE-eptA has a calculated m/z of 1673.3. Hence, ΔeptA, 371 
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ΔlpxE and ΔlpxE-eptA deletion mutant strains feature 1-phospho lipid A. While this is the 372 
variant expected to occur for ΔlpxE and ΔlpxE-eptA strains, ΔeptA had been predicted 373 
to lack the 1-phosphate, thus having a free reducing end for GlcN(I) in the lipid A 374 
backbone (m/z calculated 1575.3). However, due to the lack of a negative charged 375 
group, this de-phospho lipid A variant can’t be accessed by MS analysis in the negative 376 
ion mode. Nevertheless, the detection of 1-phospho lipid A as well in the ΔeptA deletion 377 
mutant strain is in perfect agreement with the intermediary phenotype observed in 378 
endotoxicity and CAMP resistance (Figs. 3 and 4) and the proposed non-stoichiometric 379 
activity of LpxE in the ΔeptA strain. 380 
 381 
In order to further confirm the postulated enzymatic mechanisms, we performed 382 
negative ion mode MS analysis also on complemented mutants (Fig. S2). The ΔlpxE 383 
strain could be complemented in trans with lpxE, as we confirmed the wt lipid A for the 384 
ΔlpxE strain complemented with p-lpxE (m/z calculated: 1716.3, found: 1717). The 385 
ΔlpxE strain could not be complemented in trans with eptA alone (Fig. S2) and the 386 
resulting strain showed a main peak at m/z of 1674 (Fig. S2), matching the 1-phospho 387 
lipid A variant predicted for the ΔlpxE strain (m/z calculated: 1673.3). The ΔeptA strain 388 
was complemented with eptA (Fig. S2) and the lpxE-eptA deletion mutant was 389 
complemented with lpxE-eptA (Fig. S2), as in both cases the wt lipid A for these strains 390 
was found (m/z calculated: 1716.3, found: 1717). 391 
Additional peaks measured at m/z of 1755/1769 for the ΔlpxE + p-lpxE and the ΔeptA + 392 
p-eptA strain are attributed to a minor lipid A variant with two phosphates present and 393 
possibly with a classical GlcN-GlcN backbone, know to be present in C. canimorsus 5 394 
(m/z calculated: 1755.209; peak shift of Δ14 m/z units due to acyl chain heterogeneity) 395 
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(19). The two phosphates might either be present as 1-phospho 4’-phospho lipid A or as 396 
1-pyrophosphate lipid A. Based on 1-pyrophosphate species detected in various species 397 
(42) we would hypothesize, that the peaks measured at m/z of 1755/1769 correspond to 398 
a 1-pyrophosphate variant with a classical E. coli-type GlcN-GlcN lipid A backbone. The 399 
peak measured at m/z of 1725 for the ΔlpxE + p-eptA strain is similarly attributed to a 400 
bisphosphorylated species in combination with an exchange of 17:0(3-OH) by 15:0(3-401 
OH) (m/z calculated: 1725.186). The detection of these peaks exclusively in 402 
complemented mutants and the resulting changes in acyl chain preference and 403 
backbone structure, however, deserves further clarification. 404 
We conclude from these complementation experiments that the eptA and lpxE mutations 405 
were non-polar and that in the complemented mutants, ΔlpxE + p-lpxE, ΔeptA + p-eptA 406 
and ΔlpxE-eptA + p-lpxE-eptA, the wt lipid A is reconstituted. 407 
 408 
In the positive ion mode, MS analysis confirmed the wt lipid A (m/z calculated: 1764.3, 409 
found: 1764) (Table 3 and Fig. 6). Again peak “clusters” differing by Δ14 m/z units were 410 
found for all samples. The 1-phospho lipid A variant has a calculated m/z of 1720.2 [M-411 
H++2Na+] in the positive ion mode. The main peak for ΔlpxE and ΔlpxE-eptA deletion 412 
mutants was found at m/z of 1721.6 and 1721.0, respectively. This peak was absent in 413 
the ΔeptA deletion mutant strain. The ΔeptA deletion mutant’s main peak present at m/z 414 
of 1604/1618 (peak shift of 14 m/z units due to acyl chain heterogeneity), corresponded 415 
to a free hydroxy group forms a reducing end in the lipid A backbone and has been 416 
calculated to m/z of 1603.3/1617.3. It is noteworthy that a peak at m/z of 1601 is found 417 
in all samples in the positive ion mode (and the corresponding peak shifted by 14 m/z 418 
units). The presence of 1-dephospho lipid A variants even in those mutants which 419 
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contain the 1-phospho group has been assigned as artefacts well known to appear from 420 
the wt strains due to the acid hydrolysis conditions necessary to liberate the lipid A from 421 
the phosphorylated Kdo found in the core of C. canimorsus LPS (19, 34). These 422 
conditions obviously lead to a partial de-phosphorylation at the 1 position of lipid A. Even 423 
more, the main peak from the 1-hydroxy lipid A cluster for ΔlpxE and ΔlpxE-eptA 424 
deletion mutants was found at m/z 1601 and not at m/z 1604/1618 as predicted. We 425 
assume that the peak at 1604 m/z found in the ΔeptA deletion mutant is identical to 426 
peaks at m/z of 1601 found in ΔlpxE and ΔlpxE-eptA deletion mutants. 427 
 428 
According to the proposed model, the major and representative lipid A molecule of the 429 
ΔeptA mutant lacks any charged group and, therefore, its pseudomolecular ion [M+Na+] 430 
can only be analyzed in the positive ion mode. In agreement with this, in the positive 431 
(but not the negative) ion mode of ΔeptA lipid A, the pseudomolecular ion [M+Na+] was 432 
detected. The ion [M-H+] detected in the negative ion mode of ΔeptA lipid A was likely 433 
raised from incomplete de-phosphorylated lipid A, resulting in 1-phospho lipid A. 434 
Notably, the [M-H+] ion was not detected for the ΔeptA mutant in the positive ion mode, 435 
possibly reflecting its small proportion. 436 
 437 
We further performed positive ion mode MS analysis on complemented mutants (Fig. 438 
S3). The ΔlpxE strain could be complemented in trans with lpxE, as we confirmed the wt 439 
lipid A for this strain (m/z calculated: 1764.3, found: 1764). The ΔlpxE strain could not be 440 
complemented in trans with eptA alone (Fig. S3) and the resulting strain showed a main 441 
peak at m/z 1722 (Fig. S3), matching the 1-phospho lipid A variant predicted for ΔlpxE 442 
(m/z calculated: 1720.2). The ΔeptA strain was complemented with eptA (Fig. S3) and 443 
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the lpxE-eptA deletion mutant was complemented with lpxE-eptA (Fig. S3), as in both 444 
cases the wt lipid A for these strains was found (m/z calculated: 1764.3, found: 1764). 445 
Additional peaks measured at m/z of 1803/1817 for the ΔlpxE + p-lpxE and the ΔeptA + 446 
p-eptA strain are attributed to a minor bisphosphorylated lipid A backbone variant, 447 
probably with a E. coli-type classical GlcN-GlcN backbone know also to be present in 448 
small amounts in C. canimorsus 5 (m/z calculated: 1802.196; peak shift of 14 m/z units 449 
due to acyl chain heterogeneity) (19) and correlate with additional peaks observed in the 450 
negative ion mode MS analysis of these strains. 451 
We conclude from these complementation experiments that the eptA and lpxE mutations 452 
were non-polar and that in the complemented mutants, ΔlpxE + p-lpxE, ΔeptA + p-eptA 453 
and ΔlpxE-eptA + p-lpxE-eptA, the wt lipid A is reconstituted. 454 
 455 
Overall, 1-phospho lipid A was validated as main lipid A variant in ΔlpxE and ΔlpxE-eptA 456 
deletion mutants. This confirms that LpxE acts as lipid A 1-phosphatase and further 457 
corroborates the two step enzymatic mechanism, in which EptA is only active after LpxE 458 
dependent removal of the 1-phosphate on lipid A. In agreement with endotoxicity and 459 
CAMP resistance, both 1-phospho as well as 1-de-phospho lipid A variants were found 460 
present in the ΔeptA deletion mutant. This validates the function of EptA as lipid A 461 
phosphoethanolamine transferase and again supposes a two step enzymatic activity, in 462 
which LpxE can dephosphorylate lipid A even in the absence of EptA. But LpxE seems 463 
not to dehosphorylate every lipid A in the absence of EptA, which is reflected by the 1-464 
phospho lipid A species identified in the ΔeptA deletion mutant.  465 
 466 
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The lipid A modification described in this work represents a clear virulence factor since it 467 
dramatically reduces recognition and killing by the host’s innate immune system. 468 
However, human infections are rare events and dead ends for C. canimorsus. Thus, we 469 
can envision that the lipid A modification most likely evolved as a factor favouring the 470 
adaptation of C. canimorsus to its natural niche, the dog’s mouth.  471 
 472 
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Figure legends 607 
Figure 1. Structures of C. canimorsus 5 and E. coli lipid A. (A) C. canimorsus 5 lipid A 608 
consists of a β-(1’→6)-linked GlcN3N’-GlcN disaccharide, to which 3-hydroxy-15-609 
methylhexadecanoic acid, 3-hydroxy-13-methyltetradecanoic acid, 3-O-(13-610 
methyltetradecanoyl)-15-methylhexadecanoic acid, and 3-hydroxyhexadecanoic acid 611 
are attached at positions 2, 3, 2’, and 3’, respectively. The disaccharide carries a 612 
positively charged ethanolamine at the 1-phosphate and lacks a 4’-phosphate (from ref. 613 
(19)) (B) E. coli hexa-acylated lipid A consisting of a β-(1’→6)-linked GlcN disaccharide 614 
that is phosphorylated at positions 1 and 4’ and carries four (R)-3-hydroxymyristate 615 
chains (at positions 2’, 3’, 2 and 3). The 2’ and 3’ 3-hydroxylated acyl groups in GlcN’ 616 
are further esterified with laurate and myristate, respectively (from ref. (29)). 617 
 618 
Figure 2. Schematic representation of the proposed enzymatic activity of LpxE, EptA 619 
and LpxF in the biosynthesis of C. canimorsus lipid A (top) and illustration of the lpxE-620 
eptA operon (bottom, drawn to scale) corresponding to Ccan_16960 and Ccan_16950, 621 
respectively. 622 
 623 
Figure 3. Effect of lpxE or eptA deletion on endotoxicity (A) Endotoxicity of heat-killed C. 624 
canimorsus 5 wild-type (Cc5), ΔlpxE, ΔeptA or ΔlpxE-eptA bacteria. Indicated multiplicity 625 
of infection (MOI) of heat-killed bacteria was assayed for TLR4 dependent NFκB 626 
activation with HekBlue human TLR4 cells. Data were combined from n=3 independent 627 
experiments, error bars indicated are standard error of the mean. (B-D) Same as A but 628 
the mutations were complemented in trans by the indicated plasmids. All mutations 629 
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showed to be non-polar. Data were combined from n=3 independent experiments, error 630 
bars indicated are standard error of the mean. 631 
 632 
Figure 4. Effect of lpxE or eptA deletion on resistance to Polymyxin B. MIC of Polymyxin 633 
B for wt C. canimorsus 5 (Cc5), ΔlpxE, ΔeptA or ΔlpxE-eptA C. canimorsus 5 as well as 634 
complemented mutants. Data were combined from n=3 or 4 independent experiments, 635 
where MIC measured were always identical. 636 
 637 
Figure 5. Mass spectrometric analysis of lipid A of indicated strains as analyzed by 638 
MALDI-TOF MS in the negative ion mode. 639 
 640 
Figure 6. Mass spectrometric analysis of lipid A of indicated strains as analyzed by 641 
MALDI-TOF MS in the positive ion mode. 642 
643 
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Table 1. Bacterial strains and plasmids used in this study 644 
Strains   
Cc5 Human fatal septicaemia after dog bite 1995 (30) 
Cc5 ΔlpxE Replacement of Ccan_16960 by ermF;Emr (primer 6493-6498) (∆ 1833737 - 
1833995) 
This 
study 
Cc5 ΔeptA Replacement of Ccan_16950 by ermF; Emr(primer 6499-6504) (∆ 1831370 - 
1832888) 
This 
study 
Cc5 ΔlpxE-
eptA 
Replacement of Ccan_16960-16950 by ermF;Emr (primer 6493-6495 and 
6502-6504) (∆ 1831370 - 1833995) 
This 
study 
Cc5 Y1C12 
Tn4351 insertion in Ccan_23370, “wbuB” like glycosyltransferase 
(35) 
Cc5Y1C12 
ΔlpxE 
Replacement of Ccan_16960 by tetQ;Tcr (primer 7539-7544) (∆ 1833737 - 
1833995) 
This 
study 
Cc5 Y1C12 
ΔeptA 
Replacement of Ccan_16950 by tetQ; Tcr (primer 7545-7550) (∆ 1831370 - 
1832888) 
This 
study 
Cc5 Y1C12 
ΔlpxE-eptA 
Replacement of Ccan_16960-16950 by tetQ;Tc (primers 7539; 
7540;7543;7547;7548;7550) (∆ 1831370 - 1833995) 
This 
study 
Plasmids   
p-lpxE pMM47.AlpxE (expression plasmid encoding complete lpxE gene from Cc5) This 
study 
p-lpxE-eptA pMM47.AlpxE-eptA (expression plasmid encoding complete lpxE-eptA genes 
from Cc5) 
This 
study 
p-eptA pMM47.AeptA (expression plasmid encoding complete eptA gene from Cc5) This 
study 
pMM13 ColE1 ori; Apr (Emr); ermF from pEP4351  (31) 
pMM25 ColE1 ori; Kmr(Cfr); suicide vector for C. canimorsus (31) 
pMM47.A ColE1 ori (pCC7 ori); Apr (Cfr); E. coli-C. canimorsus expression shuttle 
plasmid, C. canimorsus expression is driven by a ermF promoter  
(31) 
pMM104.A ColE1 ori (pCC7 ori); Apr (Tcr); E. coli-C. canimorsus shuttle plasmid, RP4 
oriT. PstI fragment of pMM47.A containing repA inserted into PstI site of 
pLYL001 
(31) 
pSI73 pMM25lpxE::ermF (suicide vector for deletion of lpxE, (∆ 1833737 - 
1833995)) 
This 
study 
pSI74 pMM25eptA::ermF (suicide vector for deletion of eptA, (∆ 1831370 - 
1832888)) 
This 
study 
pSI76 pMM25lpxE-eptA::ermF (suicide vector for deletion of lpxE-eptA, (∆ 1831370 
- 1833995)) 
This 
study 
  30
pFR28 pMM25lpxE::tetQ (suicide vector for deletion of lpxE, (∆ 1833737 - 1833995)) This 
study 
pFR29 pMM25eptA::tetQ (suicide vector for deletion of eptA, (∆ 1831370 - 
1832888)) 
This 
study 
pFR30 pMM25lpxE-eptA::tetQ (suicide vector for deletion of lpxE-eptA, (∆ 1831370 - 
1833995)) 
This 
study 
 645 
646 
  31
Table 2. Oligonucleotides used in this study 647 
 648 
Ref. Name Sequence 5'-3' 
Restriction 
site Gene PCR
6493 lpxE-A CCCTGCAGGGCACGTTCGTACCAGTTA PstI lpxE A 
6494 lpxE-B 
GAGTAGATAAAAGCACTGTTATTTGCTTATTTTGAATATTTC
GG  
lpxE B 
6495 lpxE-C 
CTTATATTTGCCGCCGAAATATTCAAAATAAGCAAATAACA
GTGCTTTTATCTACTCCGATAGCTTC  
ermF C 
6496 lpxE-D 
CTTGCATTATCTTAACACTCATAAAAACAACACTCCCCTAC
GAAGGATGAAATTTTTCAGGGACAAC  
ermF D 
6497 lpxE-E 
AAAAATTTCATCCTTCGTAGGGGAGTGTTGTTTTTATGAGT
GTT  
lpxE E 
6498 lpxE-F CAACTAGTAAACCGTTTCAGTTTGGGT SpeI lpxE F 
6499 eptA-A CCCTGCAGTGTTCCTCGCCCTGTTAC PstI eptA A 
6500 eptA-B 
GAGTAGATAAAAGCACTGTTTTATTGATTTTTTTTAACATAA
AATTTTATC  
eptA B 
6501 eptA-C 
GTTGTACTTAATGATAAAATTTTATGTTAAAAAAAATCAATAA
AACAGTGCTTTTATCTACTCCGATAGCTTC  
ermF C 
6502 eptA-D 
ATCTTGTAAATTACGGATTGGTCATTCAATAATTCTACGAAG
GATGAAATTTTTCAGGGACAAC  
ermF D 
6503 eptA-E AAAAATTTCATCCTTCGTAGAATTATTGAATGACCAATCCG  eptA E 
6504 eptA-F CAACTAGTTCCACCTCATTGAGATTCAC SpeI eptA F 
6646 p-lpxE-fw CGTACCATGGTTTTTAAAGAATCAGCAAATAACC NcoI lpxE  
6647 p-lpxE-rev CAGTTCTAGATTATTGATTTTTTTTAACATAAAATTTTATC XbaI lpxE  
6648 p-eptA-fw CGTACCATGGGATTAAAAAAAATCAATAAATGGACTAACA NcoI eptA  
6649 p-eptA_rev GCTTCTCGAGTTAGTCAAAAATGCTCATTTGC XhoI eptA  
7539 lpxEtetKO-A GGCTGCAGTTTCCATTCCTTTGGCACGTTCG PstI lpxE A 
7540 lpxEtetKO-B 
CAAAATCAAATGTTAAAAAAAAATTTGCTTATTTTGAATATTT
CGGC  
lpxE B 
7543 lpxEtetKO-C GCCGAAATATTCAAAATAAGCAAATTTTTTTTTAACATTTGA  tetQ C 
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TTTTG 
7544 lpxEtetKO-D 
GATTTTTTTTAACATAAAATTTTATCTTATTTTGATGACATTG
ATTTTTGG  
tetQ D 
7541 lpxEtetKO-E 
CCAAAAATCAATGTCATCAAAATAAGATAAAATTTTATGTTA
AAAAAAATC  
lpxE E 
7542 eptAtetKO-F 
GGACTAGTCAAGGTAAAGCCAATGTTAAGC 
1.1.1  SpeI lpxE F 
7545 eptAtetKO-A 
GGCTGCAGTATGGGGAGGAAAGCGTCAATATTG 
 PstI 
eptA A 
7546 eptAtetKO-B 
CAAAATCAAATGTTAAAAAAAAGCGGTACATTGTTAGTCCA
TTTATTG 
 
 eptA B 
7549 eptAtetKO-C 
CAATAAATGGACTAACAATGTACCGCTTTTTTTTAACATTTG
ATTTTG 
  
tetQ C 
7550 eptAtetKO-D 
CGGATTGGTCATTCAATAATTTTATTTTGATGACATTGATTT
TTGG 
 
 tetQ D 
7547 lpxEtetKO-E 
CCAAAAATCAATGTCATCAAAATAAAATTATTGAATGACCAA
TCCG 
 
 eptA E 
7548 eptAtetKO-F GGACTAGTCATTAAGTGCTACCCCTATCTTATC SpeI eptA F 
649 
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Table 3. MS analysis and interpretation of lipid A variants in wt, lpxE, eptA, and 650 
lpxE-eptA deletion mutant strains. 651 
______________________________________________________________________ 652 
                 wt   mutant    653 
 _______________________________________ 654 
Component  ΔlpxE ΔeptA ΔlpxE-eptA 655 
_____________________________________________________________________ 656 
GlcN 1 1 1 1 657 
GlcN3N 1 1 1 1 658 
P 1 1 0 1 659 
Etn 1 0 0 0 660 
i15:0 1 1 1 1 661 
i15:0(3-OH) 1 1 1 1 662 
16:0(3-OH) 1 1 1 1 663 
i17:0(3-OH) 1 1 1 1 664 
__________________________________________________________________ 665 
m/z calc. (neg. mode) 1716.3 1673.3 1575.3 1673.3 666 
found for [M-H+] 1716.8 1673.4 (1673.9)* 1673.1   667 
__________________________________________________________________ 668 
m/z calc. (pos. mode) 1764.3 1720.2 1603.3 1720.2  669 
found 1764 1722 1604 1722 670 
for [M-H++2Na+] [M-H++2Na+] [M+Na+] [M-H++2Na+] 671 
__________________________________________________________________ 672 
* Ion [M-H+] detected in the neg. ion mode of ΔeptA lipid A was raised from incomplete 673 
de-phosphorylated lipid A. The major and representative lipid A molecule of this mutant 674 
lacks any charged group and, therefore, its pseudomolecular ion [M+Na+] could only be 675 
analyzed in the positive ion mode. 676 
 677 






